| Literature DB >> 28295574 |
Tsuyoshi Hattori1, Minoru Kaji1, Hiroshi Ishii1, Roboon Jureepon1, Mika Takarada-Iemata1, Hieu Minh Ta1, Thuong Manh Le1, Ayumu Konno2, Hirokazu Hirai2, Yoshitake Shiraishi3, Noriyuki Ozaki3, Yasuhiko Yamamoto4, Hiroshi Okamoto4,5, Shigeru Yokoyama6, Haruhiro Higashida6, Yasuko Kitao1, Osamu Hori1.
Abstract
Glial development is critical for the function of the central nervous system. CD38 is a multifunctional molecule with ADP-ribosyl cyclase activity. While critical roles of CD38 in the adult brain such as oxytocin release and social behavior have been reported, those in the developing brain remain largely unknown. Here we demonstrate that deletion of Cd38 leads to impaired development of astrocytes and oligodendrocytes in mice. CD38 is highly expressed in the developing brains between postnatal day 14 (P14) and day 28 (P28). In situ hybridization and FACS analysis revealed that CD38 is expressed predominantly in astrocytes in these periods. Analyses of the cortex of Cd38 knockout (Cd38-/- ) mice revealed delayed development of astrocytes and subsequently delayed differentiation of oligodendrocytes (OLs) at postnatal stages. In vitro experiments using primary OL cultures, mixed glial cultures, and astrocytic conditioned medium showed that astrocytic CD38 regulates the development of astrocytes in a cell-autonomous manner and the differentiation of OLs in a non-cell-autonomous manner. Further experiments revealed that connexin43 (Cx43) in astrocytes plays a promotive role for CD38-mediated OL differentiation. Finally, increased levels of NAD+ , caused by CD38 deficiency, are likely to be responsible for the suppression of astrocytic Cx43 expression and OL differentiation. Our data indicate that CD38 is a positive regulator of astrocyte and OL development.Entities:
Keywords: NAD; autism; connexin 43; cortex; hemichannel; myelin
Mesh:
Substances:
Year: 2017 PMID: 28295574 DOI: 10.1002/glia.23139
Source DB: PubMed Journal: Glia ISSN: 0894-1491 Impact factor: 7.452